デフォルト表紙
市場調査レポート
商品コード
1379067

細胞分離市場レポート:技術、細胞タイプ、製品、用途、最終用途、地域別、2023-2028年

Cell Isolation Market Report by Technique, Cell Type, Product, Application, End Use, and Region 2023-2028

出版日: | 発行: IMARC | ページ情報: 英文 140 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.08円
細胞分離市場レポート:技術、細胞タイプ、製品、用途、最終用途、地域別、2023-2028年
出版日: 2023年11月02日
発行: IMARC
ページ情報: 英文 140 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

世界の細胞分離の市場規模は、2022年に119億米ドルに達しました。今後、IMARCグループは、市場は2028年までに285億米ドルに達し、2022年から2028年の成長率(CAGR)は15.7%になると予測しています。再生医療と細胞ベースの治療に対する需要の高まり、効率的な分離技術の必要性、慢性疾患の急増、バイオテクノロジーとライフサイエンスへの投資の増加が市場成長を増大させる要因となっています。

細胞分離は生命科学の領域における基本的な技術であり、複雑な生物学的サンプルから特定の細胞集団を分離することを含みます。このプロセスは、様々な下流の用途のために純粋な細胞サブセットを得るという原則に基づいています。サンプル採取に始まり、単一細胞を得るために組織の解離が行われます。次にこれらの細胞は、サイズ、表面マーカー、密度などの明確な特徴に基づいて分離されます。細胞単離の利点は多岐にわたる。細胞の挙動、遺伝子発現、タンパク質機能の精密な分析が可能になり、疾患研究や医薬品開発の進歩に貢献します。この技術はがん研究、免疫学、再生医療などの分野に応用されています。細胞分離には磁気活性化細胞選別(MACS)、蛍光活性化細胞選別(FACS)、密度勾配遠心法などいくつかの方法があります。

世界の細胞分離市場は、再生医療分野の拡大と効率的な細胞分離技術へのニーズの高まりの影響を受けています。さらに、慢性疾患の有病率の上昇は、高度な細胞ベースの治療法を必要とし、市場の成長を後押ししています。これに伴い、バイオテクノロジーやライフサイエンス分野への資金提供や投資が増加し、研究開発活動に拍車がかかり、市場をさらに押し上げています。さらに、個別化医療への関心の高まりが正確な細胞分離法への要求を高め、市場の成長を促進しています。これとは別に、がん研究への関心の高まりと標的治療の必要性が市場成長を促進しています。高齢化人口の増加、学術機関と業界プレイヤーの協力関係の急増など、その他の要因も市場成長を後押ししています。

細胞分離市場の動向と促進要因:

再生医療分野の拡大

世界の細胞分離市場の成長は、急成長する再生医療分野と密接に関連しています。再生医療は、損傷した組織や臓器を回復させるために細胞の潜在能力を活用することを重視し、医療治療のパラダイムに革命をもたらします。研究者が再生療法を深く掘り下げるにつれ、正確で効率的な細胞分離技術の必要性が明らかになります。高純度で特定の種類の細胞を分離することは、再生治療の成功を確実にするために不可欠です。この需要が最先端の細胞分離技術の開拓と採用を促し、市場拡大を後押ししています。

慢性疾患の有病率の上昇

慢性疾患の蔓延の高まりは、高度な細胞ベースの治療に対する差し迫ったニーズに火をつけ、細胞分離市場の著しい成長に火をつけています。心血管疾患、糖尿病、神経変性疾患などの慢性疾患は、世界の医療制度に大きな課題を突きつけています。細胞ベースの治療法は、再生や個別化された治療アプローチを提供することで、これらの課題に対処する上で計り知れない可能性を秘めています。このような治療法の可能性を活用するためには、生存可能で機能的に無傷な細胞を単離することが最も重要です。この必要性から、細胞ベースの治療の多様なニーズに応える効率的な細胞分離法を革新するための研究開発が強化され、市場の軌道を形成しています。

バイオテクノロジーとライフサイエンス分野への資金調達と投資

細胞分離市場はバイオテクノロジーとライフサイエンス分野への旺盛な資金と投資によって上昇基調にあります。政府、民間投資家、ベンチャーキャピタルは、病気治療や創薬を含む様々な用途における細胞分離技術の飛躍的進歩がもたらす変革の可能性を認識しています。その結果、多額の資金援助が細胞分離技術の改良と革新を目指す研究活動に注がれています。このような資金の流入は、新しい方法論の開発に拍車をかけるだけでなく、高度な細胞分離製品の商業化と入手を容易にします。資金投資と科学的探求の相乗効果は市場を前進させ、医療と技術進歩の最前線に位置づけています。

細胞分離産業のセグメンテーション

IMARC Groupは、世界の細胞分離市場レポートの各セグメントにおける主要動向の分析と、2023年から2028年までの世界、地域、国レベルでの予測を提供しています。当レポートでは、技術、細胞タイプ、製品、用途、最終用途に基づいて市場を分類しています。

本レポートで扱う主な質問

  • 世界の細胞分離市場の規模は?
  • 2023-2028年における世界の細胞分離市場の予想成長率は?
  • 世界の細胞分離市場を牽引する主な要因は何か
  • COVID-19が世界の細胞分離市場に与えた影響は?
  • 世界の細胞分離市場の技術別の区分は?
  • 細胞タイプに基づく細胞分離の世界市場内訳は?
  • 細胞分離の世界市場の製品別区分は?
  • 細胞分離の世界市場の用途別区分は?
  • 細胞分離の世界市場の用途別区分は?
  • 10.細胞分離の世界市場における主要地域は?
  • 11.細胞分離の世界市場における主要プレイヤー/企業は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 細胞分離の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:技術別

  • 遠心分離
    • 市場動向
    • 市場予測
  • 表面マーカー
    • 市場動向
    • 市場予測
  • ろ過
    • 市場動向
    • 市場予測

第7章 市場内訳:細胞タイプ別

  • ヒト細胞
    • 市場動向
    • 市場予測
  • 動物細胞
    • 市場動向
    • 市場予測

第8章 市場内訳:製品別

  • 消耗品
    • 市場動向
    • 主要セグメント
      • 試薬、キット、培地、血清
      • ビーズ
      • 消耗品
    • 市場予測
  • 器具
    • 市場動向
    • 主要セグメント
      • 遠心分離機
      • フローサイトメーター
      • ろ過システム
      • 磁気活性細胞分離システム
    • 市場予測

第9章 市場内訳:用途別

  • 生体分子分離
    • 市場動向
    • 市場予測
  • 治療薬
    • 市場動向
    • 市場予測
  • 幹細胞研究
    • 市場動向
    • 市場予測
  • がん調査
    • 市場動向
    • 市場予測
  • 組織再生
    • 市場動向
    • 市場予測
  • 体外診断薬
    • 市場動向
    • 市場予測

第10章 市場内訳:最終用途別

  • バイオテクノロジーとバイオ医薬品企業
    • 市場動向
    • 市場予測
  • 病院・診断研究所
    • 市場動向
    • 市場予測
  • 研究機関・研究所
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第11章 市場内訳:地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳:国別
    • 市場予測

第12章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第15章 価格分析

第16章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Alfa Laval AB
    • Becton Dickinson and Company
    • Beckman Coulter Inc.(Danaher Corporation)
    • Bio-Rad Laboratories Inc.
    • General Electric Company
    • Merck KGaA
    • Miltenyi Biotec B.V. & Co. KG
    • pluriSelect Life Science UG(haftungsbeschrankt)& Co. KG
    • Roche Holding AG
    • STEMCELL Technologies Inc.
    • Terumo Corporation
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Cell Isolation Market: Major Drivers and Challenges
  • Figure 2: Global: Cell Isolation Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Cell Isolation Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Cell Isolation Market: Breakup by Technique (in %), 2022
  • Figure 5: Global: Cell Isolation Market: Breakup by Cell Type (in %), 2022
  • Figure 6: Global: Cell Isolation Market: Breakup by Product (in %), 2022
  • Figure 7: Global: Cell Isolation Market: Breakup by Application (in %), 2022
  • Figure 8: Global: Cell Isolation Market: Breakup by End Use (in %), 2022
  • Figure 9: Global: Cell Isolation Market: Breakup by Region (in %), 2022
  • Figure 10: Global: Cell Isolation (Centrifugation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Cell Isolation (Centrifugation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Cell Isolation (Surface Marker) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Cell Isolation (Surface Marker) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Cell Isolation (Filtration) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Cell Isolation (Filtration) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Cell Isolation (Human Cells) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Cell Isolation (Human Cells) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Cell Isolation (Animal Cells) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Cell Isolation (Animal Cells) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Cell Isolation (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Cell Isolation (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Cell Isolation (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Cell Isolation (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Cell Isolation (Biomolecule Isolation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Cell Isolation (Biomolecule Isolation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Cell Isolation (Therapeutics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Cell Isolation (Therapeutics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Cell Isolation (Stem Cell Research) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Cell Isolation (Stem Cell Research) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Cell Isolation (Cancer Research) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Cell Isolation (Cancer Research) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Cell Isolation (Tissue Regeneration) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Cell Isolation (Tissue Regeneration) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Cell Isolation (In-Vitro Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Cell Isolation (In-Vitro Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Cell Isolation (Biotechnology and Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Cell Isolation (Biotechnology and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Global: Cell Isolation (Hospitals and Diagnostic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Global: Cell Isolation (Hospitals and Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Global: Cell Isolation (Research Laboratories and Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Global: Cell Isolation (Research Laboratories and Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Global: Cell Isolation (Other End Uses) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Global: Cell Isolation (Other End Uses) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: North America: Cell Isolation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: North America: Cell Isolation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: United States: Cell Isolation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: United States: Cell Isolation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Canada: Cell Isolation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Canada: Cell Isolation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Asia-Pacific: Cell Isolation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Asia-Pacific: Cell Isolation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: China: Cell Isolation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: China: Cell Isolation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Japan: Cell Isolation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Japan: Cell Isolation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: India: Cell Isolation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: India: Cell Isolation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: South Korea: Cell Isolation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: South Korea: Cell Isolation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Australia: Cell Isolation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Australia: Cell Isolation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Indonesia: Cell Isolation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Indonesia: Cell Isolation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Others: Cell Isolation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Others: Cell Isolation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Europe: Cell Isolation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Europe: Cell Isolation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Germany: Cell Isolation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Germany: Cell Isolation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: France: Cell Isolation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: France: Cell Isolation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: United Kingdom: Cell Isolation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: United Kingdom: Cell Isolation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Italy: Cell Isolation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Italy: Cell Isolation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Spain: Cell Isolation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Spain: Cell Isolation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Russia: Cell Isolation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Russia: Cell Isolation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Others: Cell Isolation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Others: Cell Isolation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Latin America: Cell Isolation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Latin America: Cell Isolation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Brazil: Cell Isolation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Brazil: Cell Isolation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Mexico: Cell Isolation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 87: Mexico: Cell Isolation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Others: Cell Isolation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 89: Others: Cell Isolation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 90: Middle East and Africa: Cell Isolation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 91: Middle East and Africa: Cell Isolation Market: Breakup by Country (in %), 2022
  • Figure 92: Middle East and Africa: Cell Isolation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 93: Global: Cell Isolation Industry: SWOT Analysis
  • Figure 94: Global: Cell Isolation Industry: Value Chain Analysis
  • Figure 95: Global: Cell Isolation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cell Isolation Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Cell Isolation Market Forecast: Breakup by Technique (in Million US$), 2023-2028
  • Table 3: Global: Cell Isolation Market Forecast: Breakup by Cell Type (in Million US$), 2023-2028
  • Table 4: Global: Cell Isolation Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 5: Global: Cell Isolation Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 6: Global: Cell Isolation Market Forecast: Breakup by End Use (in Million US$), 2023-2028
  • Table 7: Global: Cell Isolation Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 8: Global: Cell Isolation Market: Competitive Structure
  • Table 9: Global: Cell Isolation Market: Key Players
目次
Product Code: SR112023A3942

Abstract

The global cell isolation market size reached US$ 11.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 28.5 Billion by 2028, exhibiting a growth rate (CAGR) of 15.7% during 2022-2028. The escalating demand for regenerative medicine and cell-based therapies, the need for efficient isolation techniques, a surge in chronic diseases, and growing investments in biotechnology and life sciences are factors augmenting the market growth.

Cell isolation, a fundamental technique in the realm of life sciences, involves the separation of specific cell populations from complex biological samples. The process operates on the principle of obtaining pure cell subsets for various downstream applications. It begins with sample collection, followed by tissue dissociation to obtain single cells. These cells are then isolated based on distinct characteristics like size, surface markers, or density. The advantages of cell isolation are manifold. It enables precise analysis of cell behavior, gene expression, and protein function, contributing to advancements in disease research and drug development. This technique finds application in fields such as cancer research, immunology, and regenerative medicine. There are several methods of cell isolation, including magnetic-activated cell sorting (MACS), fluorescence-activated cell sorting (FACS), and density gradient centrifugation.

The global cell isolation market is influenced by the expanding field of regenerative medicine and the escalating need for efficient cell isolation techniques. Moreover, the rising prevalence of chronic diseases necessitates advanced cell-based therapies, boosting market growth. In line with this, increasing funding and investments in biotechnology and life sciences sectors fuel research and development activities, further propelling the market. Furthermore, the surging interest in personalized medicine amplifies the requirement for precise cell isolation methods, which is augmenting the market growth. Apart from this, the growing focus on cancer research and the need for targeted therapies are facilitating the market growth. Other factors, such as the escalating aging population and surging collaborations between academic institutions and industry players, are favoring the market growth.

Cell Isolation Market Trends/Drivers:

Expanding field of regenerative medicine

The growth of the global cell isolation market is intricately linked to the burgeoning field of regenerative medicine. Regenerative medicine emphasizes harnessing the potential of cells to restore damaged tissues and organs, revolutionizing medical treatment paradigms. As researchers delve deeper into regenerative therapies, the necessity for precise and efficient cell isolation techniques becomes evident. Isolation of specific cell types with high purity is imperative to ensure the success of regenerative procedures. This demand drives the development and adoption of cutting-edge cell isolation technologies, propelling market expansion.

Rising prevalence of chronic diseases

The escalating prevalence of chronic diseases has ignited a pressing need for advanced cell-based therapies, igniting significant growth in the cell isolation market. Chronic conditions such as cardiovascular diseases, diabetes, and neurodegenerative disorders pose substantial challenges to global healthcare systems. Cell-based therapies hold immense promise in addressing these challenges by offering regenerative and personalized treatment approaches. To harness the potential of such therapies, the isolation of viable and functionally intact cells is paramount. This imperative has led to intensified research and development efforts to innovate efficient cell isolation methods that cater to the diverse needs of cell-based treatments, shaping the trajectory of the market.

Funding and investments in biotechnology and life sciences sectors

The cell isolation market experiences an upward trajectory driven by robust funding and investments in the biotechnology and life sciences sectors. Governments, private investors, and venture capitalists recognize the transformative potential of breakthroughs in cell isolation techniques for various applications, including disease treatment and drug discovery. Consequently, substantial financial support is channeled into research endeavors aimed at refining and innovating cell isolation technologies. This influx of funds not only fuels the development of novel methodologies but also facilitates the commercialization and accessibility of advanced cell isolation products. The synergy between financial investments and scientific exploration propels the market forward, positioning it at the forefront of medical and technological advancement.

Cell Isolation Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global cell isolation market report, along with forecasts at the global, regional, and country levels for 2023-2028. Our report has categorized the market based on technique, cell type, product, application, and end use.

Breakup by Technique:

Centrifugation

Surface Marker

Filtration

Centrifugation dominates the market

The report has provided a detailed breakup and analysis of the market based on the technique. This includes centrifugation, surface marker, and filtration. According to the report, centrifugation represented the largest segment.

The growth of the centrifugation segment is underpinned by pivotal factors, including the growing awareness regarding the versatility offered by centrifugation techniques, such as isolating a wide range of cell types, from blood components to subcellular organelles. Moreover, the continuous advancements in centrifuge technology, leading to higher processing speeds and improved separation efficiency, contribute to its sustained adoption. Additionally, the established reliability and simplicity of centrifugation methods make them accessible to a broad spectrum of users, including researchers and clinicians. Furthermore, the compatibility of centrifugation with various sample sizes and volumes provides flexibility, catering to different experimental needs. In line with this, its compatibility with various sample sources, such as blood, tissues, and cell cultures, positions centrifugation as a versatile and essential technique in cell isolation workflows, driving its segment growth within the broader market landscape.

Breakup by Cell Type:

Human Cells

Animal Cells

Animal cells hold the largest share in the market

A detailed breakup and analysis of the market based on the cell type has also been provided in the report. This includes human cells and animal cells. According to the report, animal cells represented the largest segment.

The growth of the animal cell isolation segment is underpinned by the increasing application of animal cells in biomedical research and drug development. In line with this, the expanding field of biopharmaceuticals relies on animal cell cultures for production, intensifying the need for efficient separation methods. Additionally, the rise in regenerative medicine drives the exploration of animal cell-based therapies, necessitating high-quality isolation processes. Moreover, the surge in chronic diseases necessitates advanced disease modeling using animal cells, further propelling the segment's growth. Technological advancements in cell isolation methodologies cater to the intricate requirements of isolating animal cells, fostering market expansion. Collaborations between academic institutions and industry players facilitate knowledge exchange, contributing to innovative solutions in this segment.

Breakup by Product:

Consumables

Reagents, Kits, Media and Sera

Beads

Disposables

Instruments

Centrifuges

Flow Cytometers

Filtration Systems

Magnetic-activated Cell Separator Systems

Consumables dominate the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes consumables (reagents, kits, media and sera, beads, and disposables) and instruments (centrifuges, flow cytometers, filtration systems, and magnetic-activated cell separator systems). According to the report, consumables represented the largest segment.

The consumables segment in the cell isolation market is experiencing substantial growth due to the escalating adoption of cell-based therapies and regenerative medicine, which has led to an increased demand for consumable products used in cell isolation processes. As researchers and clinicians strive to harness the potential of cell therapies, the need for reliable and effective consumables such as reagents, kits, and disposables becomes paramount. Moreover, the rising prevalence of chronic diseases has amplified the focus on precision medicine and personalized treatments, necessitating specific consumables for isolating targeted cell populations. Additionally, advancements in consumable technologies, including improved labeling and tagging agents, have enhanced the accuracy and efficiency of cell isolation procedures. Furthermore, collaborations between research institutions and consumable manufacturers have driven innovation, leading to the development of specialized products tailored to diverse research needs.

Breakup by Application:

Biomolecule Isolation

Therapeutics

Stem Cell Research

Cancer Research

Tissue Regeneration

In-Vitro Diagnostics

Biomolecule isolation holds the largest share in the market

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes biomolecule isolation, therapeutics, stem cell research, cancer research, tissue regeneration, and in-vitro diagnostics. According to the report, biomolecule isolation represented the largest segment.

The growth of the biomolecule isolation segment is propelled by several pivotal factors, such as the expanding field of proteomics and genomics research. Additionally, the rising focus on personalized medicine necessitates the extraction of specific biomolecules for diagnostic and therapeutic purposes. Moreover, the pharmaceutical and biotechnology industries increasingly rely on biomolecule isolation to accelerate drug discovery and development processes. Technological advancements, particularly in automation and microfluidics, enhance the efficiency and scalability of isolation methods, further driving market growth. Collaborations between academic institutions and industry players facilitate knowledge exchange, leading to innovative isolation solutions. Furthermore, the growing demand for biomolecules in research applications and the biopharmaceutical sector adds impetus to the segment's expansion.

Breakup by End Use:

Biotechnology and Biopharmaceutical Companies

Hospitals and Diagnostic Laboratories

Research Laboratories and Institutes

Others

Research laboratories and institutes hold the largest share in the market

A detailed breakup and analysis of the market based on the end use has also been provided in the report. This includes biotechnology and biopharmaceutical companies, hospitals and diagnostic laboratories, research laboratories and institutes, and others. According to the report, research laboratories and institutes represented the largest segment.

The growth of the research laboratories and institutes segment is underpinned by the expanding landscape of scientific exploration, which has propelled the demand for cutting-edge technologies. Moreover, the escalating focus on advancements in healthcare and life sciences necessitates efficient cell isolation techniques, which is boosting market growth. Apart from this, collaborations between academia and industry amplify research capabilities, stimulating the need for high-quality cell isolation tools. In line with this, increasing funding and grants channel resources toward research institutions, facilitating investment in advanced isolation methodologies. Additionally, the dynamic nature of research demands versatile solutions, boosting the uptake of customizable cell isolation products. Furthermore, the continuous evolution of drug discovery and development intensifies the reliance on robust cell isolation for accurate experimentation.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest cell isolation market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America's growth in the cell isolation market is underpinned by the region's robust healthcare infrastructure and high research expenditure. Moreover, a prevalence of chronic diseases like diabetes and cardiovascular ailments drives the necessity for accurate cell-based therapies, spurring the adoption of efficient isolation methods. In line with this, the presence of major biotechnology and pharmaceutical players, coupled with strong research collaborations between academia and industry, fosters technological innovation. Furthermore, substantial funding from government initiatives and private investments fuels research and development endeavors, enhancing the market's expansion. Apart from this, an increasing focus on personalized medicine and regenerative therapies in North America amplifies the significance of precise cell isolation. Additionally, the region's regulatory framework and stringent quality standards create a conducive environment for the commercialization of innovative cell isolation products, propelling North America's prominent role in the global market.

Competitive Landscape:

The competitive landscape of the global cell isolation market is marked by dynamic factors that shape industry dynamics. Intense research and development activities drive continuous innovation, resulting in the introduction of cutting-edge cell isolation technologies. Market players strive to enhance product portfolios, offering a diverse range of isolation solutions catering to various cell types and applications. Partnerships between academia and industry foster collaborative advancement, contributing to technological breakthroughs. Regulatory compliance and quality standards remain pivotal in this landscape, influencing market entry and expansion strategies. The evolving landscape also witnesses an increasing emphasis on automation and integration of advanced techniques, aimed at improving isolation efficiency and reproducibility. As the market gains traction due to growing medical needs and scientific advancements, competition intensifies, propelling players to differentiate through product efficacy, reliability, and versatility while striving to address the ever-evolving demands of the research and healthcare sectors.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Alfa Laval AB

Becton Dickinson and Company

Beckman Coulter Inc. (Danaher Corporation)

Bio-Rad Laboratories Inc.

General Electric Company

Merck KGaA

Miltenyi Biotec B.V. & Co. KG

pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG

Roche Holding AG

STEMCELL Technologies Inc.

Terumo Corporation

Thermo Fisher Scientific Inc.

Recent Developments:

In May 2023, Beckman Coulter introduced a new advanced immunoassay analyser, DxI 9000 Access. The analyser has the capacity to conduct up to 215 tests per hour per square metre (tests/h/m²).

In May 2023, Becton Dickinson and Company announced to invest US$ 80 million in the construction of its third plant in Ciudad Juarez.

In February 2023, Alfa Laval AB is expanding production capacity for heat exchangers in Sweden, Italy, China and the US as part of an increased investment program. For this, it has decided to invest SEK 3.8 billion ($360 million) in a capacity expansion program for heat exchangers

Key Questions Answered in This Report

  • 1. How big is the global cell isolation market?
  • 2. What is the expected growth rate of the global cell isolation market during 2023-2028?
  • 3. What are the key factors driving the global cell isolation market?
  • 4. What has been the impact of COVID-19 on the global cell isolation market?
  • 5. What is the breakup of the global cell isolation market based on the technique?
  • 6. What is the breakup of the global cell isolation market based on the cell type?
  • 7. What is the breakup of the global cell isolation market based on the product?
  • 8. What is the breakup of the global cell isolation market based on the application?
  • 9. What is the breakup of the global cell isolation market based on the end use?
  • 10. What are the key regions in the global cell isolation market?
  • 11. Who are the key players/companies in the global cell isolation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cell Isolation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technique

  • 6.1 Centrifugation
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Surface Marker
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Filtration
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Cell Type

  • 7.1 Human Cells
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Animal Cells
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Product

  • 8.1 Consumables
    • 8.1.1 Market Trends
    • 8.1.2 Key Segments
      • 8.1.2.1 Reagents, Kits, Media and Sera
      • 8.1.2.2 Beads
      • 8.1.2.3 Disposables
    • 8.1.3 Market Forecast
  • 8.2 Instruments
    • 8.2.1 Market Trends
    • 8.2.2 Key Segments
      • 8.2.2.1 Centrifuges
      • 8.2.2.2 Flow Cytometers
      • 8.2.2.3 Filtration Systems
      • 8.2.2.4 Magnetic-activated Cell Separator Systems
    • 8.2.3 Market Forecast

9 Market Breakup by Application

  • 9.1 Biomolecule Isolation
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Therapeutics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Stem Cell Research
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Cancer Research
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Tissue Regeneration
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6 In-Vitro Diagnostics
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast

10 Market Breakup by End Use

  • 10.1 Biotechnology and Biopharmaceutical Companies
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals and Diagnostic Laboratories
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Research Laboratories and Institutes
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Alfa Laval AB
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Becton Dickinson and Company
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Beckman Coulter Inc. (Danaher Corporation)
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 SWOT Analysis
    • 16.3.4 Bio-Rad Laboratories Inc.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 General Electric Company
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 Merck KGaA
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
      • 16.3.6.4 SWOT Analysis
    • 16.3.7 Miltenyi Biotec B.V. & Co. KG
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Roche Holding AG
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
    • 16.3.10 STEMCELL Technologies Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Terumo Corporation
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
      • 16.3.11.4 SWOT Analysis
    • 16.3.12 Thermo Fisher Scientific Inc.
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis